Etoposide Side Effects
Recent Questions and Answers about Etoposide
What are different types of drugs that are used for leukemia?
View Community-reported Etoposide side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Etoposide Side Effect
Have You dealt with a Etoposide side effect? Share your experience
Etoposide Side Effects summary
Total Etoposide reports: 224.Etoposide FDA safety alerts: No.
Reported deaths: 113 Reported hospitalizations: 101.
Take Etoposide Side Effects Survey, Discuss Etoposide with others
Etoposide Side Effects: asthenia, dehydration, febrile neutropenia, leukopenia, pneumonia, neutropenic sepsis, renal failure acute, renal failure, thrombocytopenia, pyrexia, dyspnoea,
Etoposide Usage.
If you have questions about Etoposide, you can ask a Health Expert or Ask Patient Community about Etoposide.
Etoposide Side Effects reported to FDA
Showing 1-40 of 224 Next >
Etoposide Side Effects Report #5566479-7Health Professional from JAPAN reported ETOPOSIDE problem on Dec 17, 2007. Male patient, 22 years of age, was diagnosed with germ cell cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: prostatic abscess, pyrexia, white blood cell count decreased. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN, BLEOMYCIN SULPHATE. Patient recovered.
Etoposide Side Effects Report #5567418-5
ETOPOSIDE problem was reported by a Health Professional from FRANCE on Oct 30, 2007. Female patient, child 6 years of age, was diagnosed with t-cell type acute leukaemia, vomiting, analgesia, abdominal pain, prophylaxis and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, renal failure acute, urinary retention. ETOPOSIDE dosage: 1200 MG, CYCLICAL. During the same period patient was treated with NALBUPHINE, METOPIMAZINE, CHLOROPROMAZINE HYDROCHLORIDE, ACETAMINOPHEN, URSODIOL, PHLOROGLUCINOL, CEFTAZIDIME. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5568645-3
Health Professional from SPAIN reported ETOPOSIDE problem on Dec 02, 2007. Female patient, 15 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, cerebral venous thrombosis, partial seizures, quadriparesis, transverse sinus thrombosis. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN, BLEOMYCIN. Patient recovered.
Etoposide Side Effects Report #5569565-0
ETOPOSIDE problem was reported by a Physician from SPAIN on Dec 05, 2007. Female patient, 15 years of age, was diagnosed with germ cell cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cerebral venous thrombosis, headache, hemiplegia, papilloedema, partial seizures. ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN, BLEOMYCIN. Patient recovered.
Etoposide Side Effects Report #5569785-5
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Dec 04, 2007. Female patient, 66 years of age, weighting 231.5 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, dyspnoea, fatigue, malaise. ETOPOSIDE dosage: 100MG/M2. Patient died on 09/24/2007.
Etoposide Side Effects Report #5569845-9
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on Dec 04, 2007. Male patient, 76 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: aspiration, cardiopulmonary failure, cough, respiratory distress, vomiting. ETOPOSIDE dosage: unknown. Patient died on 04/30/2007.
Etoposide Side Effects Report #5574640-0
Health Professional from FRANCE reported ETOPOSIDE problem on Dec 18, 2007. Female patient, weighting 44.09 lb, was diagnosed with t-cell type acute leukaemia, analgesia, vomiting, prophylaxis, abdominal pain, oedema and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, hyponatraemia, renal failure acute, urinary retention. ETOPOSIDE dosage: unknown. During the same period patient was treated with NALBUPHINE, METOPIMAZINE, CHLORPROMAZINE HYDROCHLORIDE, CEFTAZIDIME, PHLOROGLUCINOL, FUROSEMIDE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5575889-3
ETOPOSIDE problem was reported by a Health Professional from POLAND on Dec 27, 2007. Male patient, 71 years of age, weighting 114.6 lb, was diagnosed with lung neoplasm malignant and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: angina pectoris. ETOPOSIDE dosage: unknown. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5506051-8
Pharmacist from UNITED STATES reported ETOPOSIDE problem on Nov 02, 2007. Male patient, 64 years of age, was diagnosed with upper respiratory tract infection and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, syncope. ETOPOSIDE dosage: 240MG ONCE IV. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5506099-3
ETOPOSIDE problem was reported by a Health Professional from POLAND on Oct 30, 2007. Male patient, 42 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: disease progression. ETOPOSIDE dosage: unknown. Patient died on 05/16/1996.
Etoposide Side Effects Report #5510162-0
Health Professional from POLAND reported ETOPOSIDE problem on Nov 05, 2007. Male patient, 42 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: disease progression. ETOPOSIDE dosage: unknown. Patient died on 05/16/1996.
Etoposide Side Effects Report #5521592-5
ETOPOSIDE problem was reported by a Health Professional from DENMARK on Nov 05, 2007. Male patient, 23 years of age, was diagnosed with medulloblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome. ETOPOSIDE dosage: 50 MG/M2 Q D X 5 D, Q 3 WEEKS. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5523223-7
Health Professional from UNITED KINGDOM reported ETOPOSIDE problem on Nov 16, 2007. Female patient, 19 years of age, was diagnosed with pain and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dilatation intrahepatic duct acquired, hepatotoxicity, liver function test abnormal, venoocclusive disease. ETOPOSIDE dosage: unknown. During the same period patient was treated with PARACETAMOL, KETALAR, NORETHINDRONE ACETATE, ACYCLOVIR, ALLOPURINOL, CASPOFUNGIN ACETATE, CHLORPHENIRAMINE, CYCLOSPORINE. Patient recovered.
Etoposide Side Effects Report #5526386-2
ETOPOSIDE problem was reported by a Health Professional from POLAND on Nov 21, 2007. Male patient, 58 years of age, was diagnosed with lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: neoplasm recurrence, respiratory failure, shock. ETOPOSIDE dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, CYTARABINE, MITOXANTRONE, ENCORTON. Patient died.
Etoposide Side Effects Report #5527994-5
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on July 20, 2007. Female patient was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: neutropenia, thrombocytopenia. ETOPOSIDE dosage: 120-130 MG FOR 3 DAYS.. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5528186-6
ETOPOSIDE problem was reported by a Consumer or non-health professional from ITALY on Nov 09, 2007. Male patient, 55 years of age, was diagnosed with oedema, prophylaxis and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, brain oedema, cerebral atrophy, cerebral haemorrhage, cognitive disorder, coma, confusional state, encephalitis herpes, hypogammaglobulinaemia. ETOPOSIDE dosage: CYCLICAL; 120 MG/M2, INTRAVENOUS. During the same period patient was treated with CISPLATIN, DEXAMETHASONE. Patient was hospitalized. Patient died.
Etoposide Side Effects Report #5528777-2
Health Professional from POLAND reported ETOPOSIDE problem on Nov 28, 2007. Male patient, 58 years of age, was diagnosed with lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, anaemia, febrile neutropenia, neoplasm recurrence, respiratory failure, shock, thrombocytopenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, CYTARABINE, MITOXANTRONE, ENCORTON. Patient died.
Etoposide Side Effects Report #5532219-0
ETOPOSIDE problem was reported by a Consumer or non-health professional from BULGARIA on Nov 13, 2007. Female patient, 27 years of age, was diagnosed with hodgkin's disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. ETOPOSIDE dosage: 200 MG/M2 IV. During the same period patient was treated with VINBLASTINE SULPHATE, VINCRISTINE, DOXORUBICIN, BLEOMYCIN, DACARBAZINE, CYCLOPHOSPHAMIDE, PROCARBAZINE, PREDNISONE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5533456-1
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Nov 14, 2007. Male patient, 53 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acanthosis, lip and/or oral cavity cancer, parakeratosis. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, CYCLOPHOSPHAMIDE, METHOTREXATE, IDARUBICIN, CYCLOSPORINE, CORTICOSTEROIDS. Patient recovered.
Etoposide Side Effects Report #5534007-8
ETOPOSIDE problem was reported by a Consumer or non-health professional from on Nov 14, 2007. Female patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: lip and/or oral cavity cancer, oral herpes. ETOPOSIDE dosage: unknown. During the same period patient was treated with DAUNORUBICIN, FLUDARABINE PHOSPHATE, CYTARABINE, CYCLOPHOSPHAMIDE, TACROLIMUS, MYCOPHENOLATE MOFETIL, METHOTREXATE. Patient recovered.
Etoposide Side Effects Report #5475501-8
Health Professional from UNITED STATES reported ETOPOSIDE problem on Sept 18, 2007. Male patient, 30 years of age, was diagnosed with testis cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: bedridden, granulocytopenia, mucosal inflammation, oral intake reduced, oral pain, platelet count decreased, stomatitis, white blood cell count decreased. ETOPOSIDE dosage: 210 MG IV. During the same period patient was treated with TAXOL, OXALIPLATIN, BLEOMYCIN, CISPLATIN. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5475885-0
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 21, 2007. Male patient was diagnosed with germ cell cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: haemorrhage. ETOPOSIDE dosage: 75 MG/M2 EVERY DAY.. During the same period patient was treated with IFOSFAMIDE, CYCLOPHOSPHAMIDE, CISPLATIN, CARBOPLATIN. Patient died.
Etoposide Side Effects Report #5476132-6
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Sept 21, 2007. Male patient was diagnosed with germ cell cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: haemorrhage. ETOPOSIDE dosage: 75 MG/M2 WAS ADMINISTERED IN ANOTHER CYCLE.. During the same period patient was treated with IFOSFAMIDE, CYCLOPHOSPHAMIDE, CISPLATIN, CARBOPLATIN. Patient died.
Etoposide Side Effects Report #5477060-2
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2007. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: chills, hypoaesthesia oral, infusion related reaction, pyrexia. ETOPOSIDE dosage: 189MG QWEEK IV. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5478041-5
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Oct 01, 2007. Female patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with ETOPOSIDE. ETOPOSIDE dosage: unknown. During the same period patient was treated with NEUPOGEN, ZOFRAN. Patient died.
Etoposide Side Effects Report #5484907-2
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 01, 2007. Male patient, 75 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: bronchopneumonia. ETOPOSIDE dosage: 100MG/M2. Patient was hospitalized. Patient died on 08/22/2007.
Etoposide Side Effects Report #5489836-6
Health Professional from UNITED KINGDOM reported ETOPOSIDE problem on Oct 12, 2007. Female patient, child 2 years of age, was diagnosed with retinoblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: myeloid leukaemia. ETOPOSIDE dosage: 100 MG/M2/D-CONSECUTIVE 5 DAYS. During the same period patient was treated with CARBOPLATIN. Patient recovered.
Etoposide Side Effects Report #5489837-8
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 21, 2007. Male patient was diagnosed with germ cell cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: infection. ETOPOSIDE dosage: 450MG/M2 EVERYDAY WAS ALSO TAKEN. During the same period patient was treated with IFOSFAMIDE, CYCLOPHOSPHAMIDE, CISPLATIN, CARBOPLATIN. Patient died.
Etoposide Side Effects Report #5489838-X
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Sept 21, 2007. Male patient was diagnosed with germ cell cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: infection. ETOPOSIDE dosage: 75 MG/M2 WAS ADMINISTERED IN ANOTHER CYCLE.. During the same period patient was treated with IFOSFAMIDE, CISPLATIN, CARBOPLATIN. Patient died.
Etoposide Side Effects Report #5490044-3
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on Oct 04, 2007. Female patient, 66 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, fatigue. ETOPOSIDE dosage: 100MG/M2. Patient died on 09/24/2007.
Etoposide Side Effects Report #5490045-5
Health Professional from UNITED STATES reported ETOPOSIDE problem on Oct 04, 2007. Male patient, 78 years of age, weighting 198.4 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: pneumonitis. ETOPOSIDE dosage: 100MG/M2, DAY 1, DAY 2, DAY 3. Patient was hospitalized. Patient died on 09/15/2007.
Etoposide Side Effects Report #5491828-8
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 01, 2007. Male patient, 50 years of age, was diagnosed with b-cell lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE, IODINE, RITUXIMAB, IFOSFAMIDE, CARBOPLATIN. Patient recovered.
Etoposide Side Effects Report #5492073-2
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Oct 01, 2007. Male patient, 50 years of age, was diagnosed with b-cell lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, thrombocytopenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE, IODINE, RITUXIMAB, IFOSFAMIDE, CARBOPLATIN. Patient recovered.
Etoposide Side Effects Report #5495283-3
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on Oct 10, 2007. Male patient, 65 years of age, weighting 178.6 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: convulsion, disease progression. ETOPOSIDE dosage: 190 MG IV. Patient was hospitalized. Patient died on 09/25/2007.
Etoposide Side Effects Report #5495289-4
Health Professional from UNITED STATES reported ETOPOSIDE problem on Oct 11, 2007. Female patient, 78 years of age, weighting 198.4 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: disease progression, pneumonitis. ETOPOSIDE dosage: 100 MG/M2, DAY 1, DAY 2, DAY 3 O. Patient was hospitalized. Patient died on 09/15/2007.
Etoposide Side Effects Report #5497861-4
ETOPOSIDE problem was reported by a Consumer or non-health professional from SOUTH AFRICA on Aug 02, 2007. Male patient, 65 years of age, weighting 178.6 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: convulsion, creatinine renal clearance increased, haematocrit decreased, haemoglobin decreased, mean cell haemoglobin concentration increased, mean cell haemoglobin increased, platelet count increased, red blood cell count decreased, red cell distribution width increased. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5497862-6
Consumer or non-health professional from NETHERLANDS reported ETOPOSIDE problem on Oct 04, 2007. Male patient, 78 years of age, weighting 198.4 lb, was diagnosed with small cell lung cancer extensive stage and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: disease progression, pneumonitis. ETOPOSIDE dosage: 100 MG/M2, DAY 1, 2 + 3 OF A 21 DAY CYCLE; INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5501571-4
ETOPOSIDE problem was reported by a Health Professional from UNITED KINGDOM on Oct 26, 2007. Female patient was diagnosed with germ cell cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: sepsis. ETOPOSIDE dosage: 90MG/M2DAYS 1-4 OVER2H:METHOTREXATE LOADING DOSE OVER 30MIN FOLLOWED BY 12HINFUSION. During the same period patient was treated with CISPLATIN, METHOTREXATE, DACTINOMYCIN, CARBOPLATIN, NEUPOGEN, LEUCOVORIN. Patient died.
Etoposide Side Effects Report #5503178-1
Pharmacist from UNITED STATES reported ETOPOSIDE problem on Oct 29, 2007. Male patient, 64 years of age, was diagnosed with neoplasm malignant and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: syncope. ETOPOSIDE dosage: 240MG ONCE IV. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5446128-9
ETOPOSIDE problem was reported by a Consumer or non-health professional from FRANCE on Aug 09, 2007. Female patient, 17 years of age, was diagnosed with hodgkin's disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, oedema, pain in extremity, purpura, toxic epidermal necrolysis, weight increased. ETOPOSIDE dosage: 280 MG (280 MG,1 IN 1 D);. During the same period patient was treated with NAVELBINE, HOLOXAN, MITOGUAZONE, AMIKACIN, FORTUM, BACTRIM, VANCOMYCIN, GRAMOCYTE. Patient was hospitalized. Patient recovered.
Showing 1-40 of 224 Next >